95 related articles for article (PubMed ID: 12817014)
1. A single intratracheal dose of the growth factor Fms-like tyrosine kinase receptor-3 ligand induces a rapid differential increase of dendritic cells and lymphocyte subsets in lung tissue and bronchoalveolar lavage, resulting in an increased local antibody production.
Pabst R; Lührmann A; Steinmetz I; Tschernig T
J Immunol; 2003 Jul; 171(1):325-30. PubMed ID: 12817014
[TBL] [Abstract][Full Text] [Related]
2. Flt3 ligand preferentially increases the number of functionally active myeloid dendritic cells in the lungs of mice.
Masten BJ; Olson GK; Kusewitt DF; Lipscomb MF
J Immunol; 2004 Apr; 172(7):4077-83. PubMed ID: 15034019
[TBL] [Abstract][Full Text] [Related]
3. Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumor immunity in vivo.
Borges L; Miller RE; Jones J; Ariail K; Whitmore J; Fanslow W; Lynch DH
J Immunol; 1999 Aug; 163(3):1289-97. PubMed ID: 10415026
[TBL] [Abstract][Full Text] [Related]
4. DNA-encoded fetal liver tyrosine kinase 3 ligand and granulocyte macrophage-colony-stimulating factor increase dendritic cell recruitment to the inoculation site and enhance antigen-specific CD4+ T cell responses induced by DNA vaccination of outbred animals.
Mwangi W; Brown WC; Lewin HA; Howard CJ; Hope JC; Baszler TV; Caplazi P; Abbott J; Palmer GH
J Immunol; 2002 Oct; 169(7):3837-46. PubMed ID: 12244180
[TBL] [Abstract][Full Text] [Related]
5. Local pulmonary immune stimulation by the Toll-like receptor 2 and 6 ligand MALP-2 in rats is age dependent.
Lührmann A; Grote K; Stephan M; Tschernig T; Pabst R
Immunol Lett; 2007 Feb; 108(2):167-73. PubMed ID: 17275100
[TBL] [Abstract][Full Text] [Related]
6. Modulating dendritic cells to optimize mucosal immunization protocols.
Williamson E; Westrich GM; Viney JL
J Immunol; 1999 Oct; 163(7):3668-75. PubMed ID: 10490961
[TBL] [Abstract][Full Text] [Related]
7. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo.
Pulendran B; Banchereau J; Burkeholder S; Kraus E; Guinet E; Chalouni C; Caron D; Maliszewski C; Davoust J; Fay J; Palucka K
J Immunol; 2000 Jul; 165(1):566-72. PubMed ID: 10861097
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte subsets in distinct lung compartments show a different ability to produce interferon-gamma (IFN-gamma) during a pulmonary immune response.
Klemm A; Tschernig T; Krug N; Pabst R
Clin Exp Immunol; 1998 Aug; 113(2):252-7. PubMed ID: 9717975
[TBL] [Abstract][Full Text] [Related]
9. A single nasal dose of fms-like tyrosine kinase receptor-3 ligand, but not peritoneal application, enhances nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
Kodama S; Hirano T; Noda K; Abe N; Suzuki M
Vaccine; 2010 Mar; 28(13):2510-6. PubMed ID: 20117272
[TBL] [Abstract][Full Text] [Related]
10. Murine Flt3 ligand expands distinct dendritic cells with both tolerogenic and immunogenic properties.
Miller G; Pillarisetty VG; Shah AB; Lahrs S; DeMatteo RP
J Immunol; 2003 Apr; 170(7):3554-64. PubMed ID: 12646617
[TBL] [Abstract][Full Text] [Related]
11. Recruitment of lymphocytes and dendritic cells from the blood to the bronchoalveolar space and the draining lymph nodes after a single intrabronchial application of the lipopeptide MALP-2.
Tschernig T; Lührmann A; Pabst R
Pathobiology; 2002-2003; 70(5):260-5. PubMed ID: 12771506
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic treatment with fms-like tyrosine kinase-3 ligand after burn injury enhances global immune responses to infection.
Bohannon J; Cui W; Cox R; Przkora R; Sherwood E; Toliver-Kinsky T
J Immunol; 2008 Mar; 180(5):3038-48. PubMed ID: 18292526
[TBL] [Abstract][Full Text] [Related]
13. No defect in T-cell priming, secondary response, or tolerance induction in response to inhaled antigens in Fms-like tyrosine kinase 3 ligand-deficient mice.
Walzer T; Brawand P; Swart D; Tocker J; De Smedt T
J Allergy Clin Immunol; 2005 Jan; 115(1):192-9. PubMed ID: 15637568
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cells recruitment and in vivo priming of CD8+ CTL induced by a single topical or transepithelial immunization via the buccal mucosa with measles virus nucleoprotein.
Etchart N; Desmoulins PO; Chemin K; Maliszewski C; Dubois B; Wild F; Kaiserlian D
J Immunol; 2001 Jul; 167(1):384-91. PubMed ID: 11418674
[TBL] [Abstract][Full Text] [Related]
15. Local proliferation contributes to lymphocyte numbers in normal lungs.
Tschernig T; Hoffmann A; Pabst R
Exp Toxicol Pathol; 2001 Jun; 53(2-3):187-94. PubMed ID: 11484838
[TBL] [Abstract][Full Text] [Related]
16. Flt3 ligand bioactivity and pharmacology in neoplasia.
Reber AJ; Ashour AE; Robinson SN; Talmadge JE; Solheim JC
Curr Drug Targets Immune Endocr Metabol Disord; 2004 Jun; 4(2):149-56. PubMed ID: 15180455
[TBL] [Abstract][Full Text] [Related]
17. Flt-3 ligand reverses late allergic response and airway hyper-responsiveness in a mouse model of allergic inflammation.
Edwan JH; Perry G; Talmadge JE; Agrawal DK
J Immunol; 2004 Apr; 172(8):5016-23. PubMed ID: 15067083
[TBL] [Abstract][Full Text] [Related]
18. The FMS-like tyrosine kinase-3 ligand/lung dendritic cell axis contributes to regulation of pulmonary fibrosis.
Tort Tarrés M; Aschenbrenner F; Maus R; Stolper J; Schuette L; Knudsen L; Lopez Rodriguez E; Jonigk D; Kühnel MP; DeLuca D; Prasse A; Welte T; Gauldie J; Kolb MR; Maus UA
Thorax; 2019 Oct; 74(10):947-957. PubMed ID: 31076499
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.
Liu Y; Huang H; Chen Z; Zong L; Xiang J
J Gene Med; 2003 Aug; 5(8):668-80. PubMed ID: 12898636
[TBL] [Abstract][Full Text] [Related]
20. Intratracheal priming with ovalbumin- and ovalbumin 323-339 peptide-pulsed dendritic cells induces airway hyperresponsiveness, lung eosinophilia, goblet cell hyperplasia, and inflammation.
Sung S; Rose CE; Fu SM
J Immunol; 2001 Jan; 166(2):1261-71. PubMed ID: 11145709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
